when raymond vles was diagnosed in 2010 with
chronic lymphocytic leukemia
(cll), a cancer of the blood and bone marrow, his doctor told him not to worry, that it could be years before he required treatment. “so being good on denial, i kind of denied it,” says vles, who was 54 at the time he was diagnosed after a routine blood test.
he rode that denial until 2017, when he noticed visible lymph nodes on his neck, and started feeling increasingly tired. he went back to his doctor who, after running more tests, including those for hemoglobin and platelet counts, confirmed the slow-moving cancer had progressed. the following year vles underwent chemo-immunotherapy. chemotherapy uses drugs to kill or slow the growth of cancer cells, immunotherapy stimulates or restores the ability of the immune system to fight the cancer.
treatment, however, depends on the patient’s age, cancer stage, overall health and fitness as well as personal preferences and can include chemotherapy, radiation therapy, targeted drug therapy, surgery or supportive therapies such as antibiotics, antivirals, transfusions, or immunoglobulin infusions. life expectancy also depends on the patient’s age, gender, stage at diagnosis, whether the abnormal blood cells are spread out or clumped, and areas of lymphatic tissue affected.
“i was able to last eight years before being treated and since then i’ve been in remission,” says vles, who now serves as board chair of the advocacy group
cll canada
. “i have a 50 per cent chance that it won’t come back. everything seems to be going well so far, fingers and toes crossed.”